stockrowDanaher Corporation
DHR Healthcare Diagnostics & Research
Danaher Corporation’s revenue for fiscal 2025 (year ended December 2025) was $24.6 billion, up 2.90% from fiscal 2024.
- Revenue
- +8.28%
- EPS
- +36.7%
- Free cash flow
- +19.1%
- Total debt
- +44.9%
Quarter to September 2026, against a year earlier
Follow DHR
Alert me
Danaher Corporation (DHR) Shares outstanding
Danaher Corporation's shares outstanding at the end of fiscal 2025 was $716.1M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $706.8M. Over the past ten years it has ranged from $699.8M (fiscal 2016) to $743.1M (fiscal 2023); the current reading is higher than 45% of that period. Danaher Corporation ranks 2nd of 49 Diagnostics & Research companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $716.1M | (2.86%) |
| FY2024 | $737.2M | (0.79%) |
| FY2023 | $743.1M | 0.81% |
| FY2022 | $737.1M | 0.04% |
| FY2021 | $736.8M | 2.52% |
| FY2020 | $718.7M | (0.94%) |
| FY2019 | $725.5M | 2.15% |
| FY2018 | $710.2M | 0.58% |
| FY2017 | $706.1M | 0.90% |
| FY2016 | $699.8M | (1.23%) |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $706.8M | (0.11%) |
| Jun 2026 | $707.6M | (0.51%) |
| Mar 2026 | $711.2M | (0.68%) |
| Dec 2025 | $716.1M | 0.34% |
| 43 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| DHR Danaher Corporation | $706.8M |
| TMO Thermo Fisher Scientific Inc. compare | $371.0M |
| A Agilent Technologies, Inc. compare | $283.0M |
| IQV IQVIA Holdings Inc. compare | $167.0M |
| ILMN Illumina, Inc. compare | $154.0M |
| NTRA Natera, Inc. compare | $144.1M |
| WAT Waters Corporation compare | $98.7M |
| IDXX IDEXX Laboratories, Inc. compare | $79.0M |
| MTD Mettler-Toledo International, Inc. compare | $20.2M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on DHR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement